Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Juvenile idiopathic arthritis" and "Society guideline links: Psoriasis" and "Society guideline links: Spondyloarthritis".)
International
●Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): Treatment recommendations for psoriatic arthritis, 2015 (published 2016)
Canada
●CRA/SPARCC: Treatment recommendations for the management of spondyloarthritis – Part II: Specific management recommendations, 2014 update (published 2015)
United States
Europe
●European League Against Rheumatism (EULAR): Recommendations for the management of psoriatic arthritis with pharmacological therapies, 2019 update (published 2020)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Clinical guideline on psoriasis – Assessment and management (2012, updated 2017)
●NICE: Guideline on spondyloarthritis in over 16s − Diagnosis and management (2017)
●NICE: Quality standard on psoriasis (2013)
Japan
●[In Japanese] Japanese Dermatological Association (JDA): Psoriatic arthritis practice guidelines (2019)